Cabaletta Bio, Inc.
CABA
$2.75
$0.041.48%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.59M | 6.94M | 6.42M | 6.76M | 8.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.02M | 44.30M | 42.61M | 46.59M | 45.91M |
| Operating Income | -52.02M | -44.30M | -42.61M | -46.59M | -45.91M |
| Income Before Tax | -51.02M | -43.52M | -41.92M | -44.87M | -45.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -51.02M | -43.52M | -41.92M | -44.87M | -45.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.02M | -43.52M | -41.92M | -44.87M | -45.13M |
| EBIT | -52.02M | -44.30M | -42.61M | -46.59M | -45.91M |
| EBITDA | -51.65M | -43.96M | -42.26M | -46.24M | -45.44M |
| EPS Basic | -0.34 | -0.39 | -0.40 | -0.44 | -0.73 |
| Normalized Basic EPS | -0.21 | -0.24 | -0.25 | -0.27 | -0.46 |
| EPS Diluted | -0.34 | -0.39 | -0.40 | -0.44 | -0.73 |
| Normalized Diluted EPS | -0.21 | -0.24 | -0.25 | -0.27 | -0.46 |
| Average Basic Shares Outstanding | 151.16M | 112.03M | 104.80M | 102.26M | 61.88M |
| Average Diluted Shares Outstanding | 151.16M | 112.03M | 104.80M | 102.26M | 61.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |